Skip to content

Psilocybin: all studies

Page 40 of 439: studies 391 to 400 of 4,389, newest first. Back to the psilocybin overview

Research

A Randomized Controlled Trial of Psilocybin for the Treatment of Obsessive-Compulsive Disorder

Online Publication Service of Würzburg University (Würzburg University) 2026 Katja Ehrmann

Obsessive Compulsive Disorder (OCD) is a prevalent mental disorder, with a lifetime prevalence of 2-3%, characterized by intrusive thoughts (obsessions) and repetitive behaviors (compulsions). These thoughts and behaviors take up a significant amount of time, cause immense distress, and compromise the quality of life of those who suffer from OCD. In addition to psychological factors such as...

Psilocybin for Treatment-Resistant OCD: A Randomised Controlled Trial

SSRN Electronic Journal 2026 Ben Kelemndi, Thomas G. Adams, Terence H. W. Ching et al. 1 citation preprint

Background: Obsessive-compulsive disorder (OCD) affects 2–3% of the population worldwide, and 40–60% of patients do not respond to first-line treatments. We evaluated the efficacy and safety of a single dose of psilocybin in adults with treatment-resistant OCD.Methods: In this phase 2, randomised, double-blind, placebo-controlled trial at the Connecticut Mental Health Center, Yale University...

DOI: 10.2139/ssrn.6218466 (opens in new tab) Psilocybin Adverse effect Randomized controlled trial Population +4

Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder.

Annals of Medicine and Surgery 2026 Sana Rasheed, Rida Arif, Ahmed Asad Raza et al. 1 citation

Psilocybin, a naturally occurring psychedelic compound, has received attention as a novel therapeutic option for major depressive disorder (MDD), particularly in cases where traditional treatments prove ineffective. The study aims to evaluate psilocybin's therapeutic potential by examining its efficacy, safety, and mechanisms of action as well as addressing the societal and regulatory...

Systematic study of Panaeolus (Agaricales, Galeropsidaceae) sensu lato and psilocybin-producing traits of species from China.

IMA fungus 2026 Mao-Qiang He, Wen-Qiang Yang, Dorji Phurbu et al.

Panaeolus sensu lato is a group of hallucinogenic mushrooms commonly found on dung, in pasture areas, grasslands, and forests. Previous studies indicated that the Panaeolus s.l. clade (panaeo-clade) could be ranked as a family (Galeropsidaceae), pending further evidence. In this study, based on phylogenomic, multigene phylogenetic, molecular clock, and morphological analyses, the panaeo-clade...

DOI: 10.3897/imafungus.17.167329 (opens in new tab) Full text (opens in new tab) Agaricineae Galeropsidaceae Hallucinogenic mushrooms Psychedelic fungi

Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications

Progress in Neuro-Psychopharmacology and Biological Psychiatry 2026 Cheng-Teng Ip, Sebastian Olbrich, Mateo de Bardeci et al. 1 citation

BACKGROUND: Recent advancements in psychedelic research have highlighted psilocybin's potential therapeutic benefits for various mental disorders. Understanding its effects on brain function and identifying predictors of individual responses are essential for developing effective treatments. METHODS: This double-blind, randomized, crossover, and placebo-controlled study enrolled 25 healthy...

DOI: 10.1016/j.pnpbp.2026.111626 (opens in new tab) Electroencephalography Dynamics music Neurophysiology Artificial neural network +2

Perceptions of Psilocybin-Assisted Psychotherapy and Standard Interventions for Nicotine Cessation

Journal of Psychoactive Drugs 2026 Philip Kamilar-Britt, Alyssa B. Oliva, Mitch Earleywine

Nicotine dependence remains a leading cause of preventable mortality worldwide. Pharmacotherapy and behavioral interventions offer modest efficacy with limited long-term success. Psilocybin-assisted psychotherapy (PAP) is an emerging approach to nicotine cessation with a growing evidence base. As PAP research expands, understanding how nicotine users' attitudes shape treatment engagement...

DOI: 10.1080/02791072.2025.2607724 (opens in new tab) Psychological intervention Credibility Smoking cessation Clinical psychology +8

Systematic study of Panaeolus (Agaricales, Galeropsidaceae) sensu lato and psilocybin-producing traits of species from China

Global Biodiversity Information Facility 2026 Mao-Qiang He, Wen-Qiang Yang, Dorji Phurbu et al.

This dataset contains the digitized treatments in Plazi based on the original journal article He, Mao-Qiang, Yang, Wen-Qiang, Phurbu, Dorji, Liu, Fei, Li, Jia-Xin, Cao, Bin, Zhao, Rui-Lin (2026): Systematic study of Panaeolus (Agaricales, Galeropsidaceae) sensu lato and psilocybin-producing traits of species from China. IMA Fungus 17: e 167329, DOI: 10.3897/imafungus.17.167329AbstractPanaeolus...

DOI: 10.15468/hc8tz2 (opens in new tab) Subgenus Sensu Clade Taxonomy biology +5

Pharmacological Management of Anxiety in End‐of‐Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin

Human Psychopharmacology: Clinical and Experimental 2026 Brunno Freitas Da Costa, Paula Hartmann, Daniel Pagnin

ABSTRACT Objective Anxiety is common in patients receiving end‐of‐life care and significantly impacts their quality of life. However, pharmacological management remains challenging due to complex clinical presentations and potential side effects, emphasizing the need for systematically reviewing existing treatments. Here we aim to systematically evaluate the efficacy and safety of...

The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures

Journal of Psychopharmacology 2026 Petr Scholle, Štěpán Wenke, Tereza Nekovářová et al. 1 citation

Background: Although psychedelics have regained attention as potential treatment tools for various mental disorders, little research has examined their impact on temporal perception. Aims: This double-blinded placebo-controlled study aimed to investigate changes in temporal perception under psilocybin, both through performance during the Temporal Bisection Task (TBT) and through subjective...

An open-label pilot study of psilocybin-assisted therapy for binge eating disorder

Figshare 2026 Jesse Dallery, Jennifer L. Miller, Jeff Boissoneault et al. preprint

Abstract Binge Eating Disorder (BED) is the most prevalent eating disorder and is associated with psychiatric comorbidities, health impairments, and decreased quality of life. Emerging evidence suggests that psilocybin-assisted therapy may promote cognitive and emotional flexibility and disrupt maladaptive behavioral patterns, making it a promising candidate for BED treatment. This open-label...

DOI: 10.6084/m9.figshare.c.8275172 (opens in new tab) Anxiety Binge-eating disorder Context archaeology Cognitive behavioral therapy +13